metomidate has been researched along with Adenoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, M; Cuthbertson, DJ; Gurnell, M; Hardy, R; Helliwell, T; Ouyang, J | 1 |
Becherer, A; Dudczak, R; Kletter, K; Mitterhauser, M; Niederle, B; Pirich, C; Vierhapper, H; Wadsak, W; Zettinig, G | 1 |
1 trial(s) available for metomidate and Adenoma
Article | Year |
---|---|
Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Carbon Radioisotopes; Etomidate; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Steroid 11-beta-Hydroxylase; Tissue Distribution | 2004 |
1 other study(ies) available for metomidate and Adenoma
Article | Year |
---|---|
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Etomidate; Humans; Positron Emission Tomography Computed Tomography | 2017 |